{"database": "lobbying", "table": "lobbying_activities", "rows": [[3251161, "7318f1d9-4091-415f-aa37-8073c187a2c2", "Q3", "MEHLMAN CONSULTING, INC.", 284950, "WEDGEWOOD PHARMACY LLC", 2024, "third_quarter", "ANI", "Issues related to animal drug compounding. FDA'S CVM GFI #256, - Compounding Animal Drugs from Bulk Substances.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2024-10-18T15:13:16-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3251161"], "units": {}, "query_ms": 42.263893177732825, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}